Tag: Jubilant
Jubilant Biosys seals deal with Pierre Fabre SA
To acquire R&D center at Saint-Julien-en-Genevois, France
Jubilant Biosys to expand its footprint in Europe, add drug discovery...
Through a series of collaborative and acquisition deals, company aims to develop a unique delivery model tailored for its customers
Jubilant launches JUBI-R, its generic version of COVID-19 drug remdesivir in...
Jubilant Generics, a subsidiary of Jubilant Life Sciences has launched remdesivir for injection under the brand name ‘JUBI-R’ in the Indian market at a price of INR 4,700 per vial of 100 mg (lyophilized injection)........................
Jubilant announces price increase of 10% for Vitamin B3
Jubilant Life Sciences is the second largest producer of Vitamin B3 globally.................................
Jubilant Life Sciences records net profit of 2% at Rs 152...
For the entire 2017-18 financial year, the company posted a net profit of Rs 634.42 crore as against Rs 574.62 crore in 2016-17..........
Jubilant Life Sciences reports record performance in 3rd quarter of ...
The company registered its highest ever revenues at Rs 2,068 crore with profits upto 42 percent year on year.......